Gamma heavy chain disease (γ-HCD) as iatrogenic immunodeficiency- associated lymphoproliferative disorder: Possible emergent subtype of rheumatoid arthritis-associated γ-HCD-Reference-Cited by-同舟云学术

Gamma heavy chain disease (γ-HCD) as iatrogenic immunodeficiency- associated lymphoproliferative disorder: Possible emergent subtype of rheumatoid arthritis-associated γ-HCD

Published:2019 Issue:4 Volume:59 Page:196-201
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Tsunemine Hiroko,Zushi Yuriko,Sasaki Miho,Nishikawa Yuko,Tamura Akiyo,Aoyama Yumi,Kodaka Taiichi,Itoh Tomoo,Takahashi Takayuki

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/59/4/59_19025/_pdf

Reference26 articles.

1. 1 Franklin EC, Lowenstein J, Bigelow B, Meltzer M. Heavy chain disease—A new disorder of serum γ-globulins. Am J Med. 1964; 37: 332-350.

2. 2 Osserman EF, Takatsuki K. Clinical and immunochemical studies of four cases of heavy (Hγ2) chain disease. Am J Med. 1964; 37: 351-373.

3. 3 Fermand JP, Brouet JC, Danon F, Seligmann M. Gamma heavy chain “disease”: heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Medicine (Baltimore). 1989; 68: 321-335.

4. 4 Wahner-Roedler DL, Kyle RA. Heavy chain diseases. Best Pract Res Clin Haematol. 2005; 18: 729-746.

5. 5 Cook JR, Harris NL, Isaacson PG, Jaffe ES. Heavy chain diseases. In: Swerdlow SH, Campo E, Harris NL, et al. (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC, World Health Organization. 2017; pp. 237-240.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab/infliximab/methotrexate;Reactions Weekly;2020-07